FDA NDC Directory · JSON-LD · Markdown
NDC 68382-529 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SUSPENSION
| Labeler / Manufacturer | Zydus Pharmaceuticals (USA) Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA202902 |
| Dosage form / route | POWDER, FOR SUSPENSION · ORAL |
| Active ingredients | CHOLESTYRAMINE (4 g/5.5g) |
| Marketing started | 20170608 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).